87 /100
CRITICAL RISK
Score updated Jul 13, 2026

COCH — Envoy Medical, Inc. Dilution Risk Tracker

Track COCH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track COCH — Get alerts when the score changes →

As of July 13, 2026, Envoy Medical, Inc. (COCH) has a DilutionWatch DilutionScore of 87/100, rated CRITICAL dilution risk. Envoy Medical, Inc. has a market capitalization of $54.24M, 76.88M shares outstanding, 36 institutional holders tracked. Key dilution vectors include 500.0K outstanding warrants, approximately 3 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
95
📊 Float Risk
55
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
64%
🔄 Reverse Split 70%
• 50-day avg $0.69 below $1 exchange minimum
• Only 3 months cash — financial pressure
🔁 Convertible Conversion 60%
• Major convertible overhang: 62% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise 55%
• Critical: only 2.8 months cash remaining
🔔 Track COCH — Get forecast alerts →

💹 Market Data

Market Cap$54.24M
Shares Outstanding76.88M
Float38.12M
Cash$4.22M
Debt$889.0K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 9.5% shares (2026Q1 vs prior)
36 institutional holders · 5.67M shares
#1 ARISTEIA CAPITAL, L.L.C. 1.14M shares
#2 TORONTO DOMINION BANK 534.7K shares
#3 Clear Street Group Inc. 301.0K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest983.8K
Days to Cover1.0
% of Float2.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for COCH Shareholders

Envoy Medical, Inc. (COCH) carries a DilutionScore of 87/100, placing it in the Critical dilution risk tier — the highest category tracked by DilutionWatch. Companies at this level typically have active capital-raising programs, compressed cash runway, or a combination of dilution vectors that together represent meaningful downside risk to share count. As of July 13, 2026, this score reflects real-time data pulled directly from SEC EDGAR filings.

DilutionWatch tracks 500,000 outstanding warrants for COCH. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window. Cash runway is a key watch item: COCH has approximately 3 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for COCH in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for COCH alongside comparable critical-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track COCH Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking COCH — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for COCH
📊 COCH FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 COCH Signal Convergence & Dark Pool Activity — StonkWhisper 📄 COCH Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.